With the release of new guidelines for treating and managing cholesterol, there may be questions not only about the changes in the update but about cholesterol itself. Most people know that high cholesterol is bad. But there’s a bigger picture involved when determining what’s considered too high. Put another way, the same number could be...
Tag: <span>low-density lipoprotein (LDL) cholesterol</span>
Post
PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms
Barcelona, Spain – 28 Aug 2017: PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to research presented today at ESC Congress.1 T cells and dendritic cells are common in atherosclerotic plaques. Atherosclerosis is a chronic inflammatory process in which activation of...